tiprankstipranks
Trending News
More News >
Revelation Biosciences (REVB)
NASDAQ:REVB
US Market

Revelation Biosciences (REVB) Financial Statements

Compare
292 Followers

Revelation Biosciences Financial Overview

Revelation Biosciences's market cap is currently $3.46M. The company's EPS TTM is $-1.65; its P/E ratio is -0.02; Revelation Biosciences is scheduled to report earnings on February 26, 2026, and the estimated EPS forecast is $-1.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -9.07B$ -7.98M$ -8.66M$ -10.86M$ -11.95M
EBITDA$ -14.84B$ -7.95M$ -8.63M$ -10.84M$ -11.93M
Net Income$ -14.87B$ -15.04M$ -120.25K$ -10.83M$ -11.99M
Balance Sheet
Cash & Short-Term Investments$ 10.70B$ 6.50M$ 11.99M$ 5.25M$ 1.27M
Total Assets$ 11.58B$ 6.62M$ 12.21M$ 5.50M$ 2.04M
Total Debt$ 746.78M$ 0.00$ 0.00$ 0.00$ 16.75K
Net Debt$ -9.95B$ -6.50M$ -11.99M$ -5.25M$ -1.26M
Total Liabilities$ 2.72B$ 1.91M$ 5.56M$ 4.45M$ 2.14M
Stockholders' Equity$ 8.86B$ 4.71M$ 6.65M$ 1.05M$ -99.47K
Cash Flow
Free Cash Flow$ -8.27B$ -18.34M$ -7.29M$ -11.22M$ -11.22M
Operating Cash Flow$ -8.27B$ -18.32M$ -7.29M$ -11.22M$ -11.09M
Investing Cash Flow$ 0.00$ -19.17K$ 0.00$ 0.00$ -131.96K
Financing Cash Flow$ 12.47B$ 12.85M$ 14.03M$ 15.20M$ 8.00M
Currency in USD

Revelation Biosciences Earnings and Revenue History

Revelation Biosciences Debt to Assets

Revelation Biosciences Cash Flow

Revelation Biosciences Forecast EPS vs Actual EPS